SANIMED SOCIÉTÉ ANONYME |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.25 TND | +4.17% |
|
+4.17% | -0.79% |
| 2023 | Sanimed Société Anonyme Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
| 2023 | Sanimed Société Anonyme Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
Valuation
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 54.56 | 54.56 | 23.56 | 21.7 | 27.65 | 21.2 |
| Enterprise Value (EV) 1 | 87.14 | 107.2 | 92 | 102.6 | 123.9 | 118.7 |
| P/E ratio | 25.2 x | 54.9 x | -6.28 x | -1.67 x | -142 x | -2.13 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 1.43 x | 1.17 x | 0.55 x | 0.61 x | 0.44 x | 0.36 x |
| EV / Revenue | 2.28 x | 2.29 x | 2.16 x | 2.9 x | 1.96 x | 2.04 x |
| EV / EBITDA | 10.6 x | 11.3 x | 19.4 x | -66.3 x | 10.7 x | 42.8 x |
| EV / FCF | -7.23 x | -5.45 x | -6.66 x | -15.9 x | -5.48 x | 70.9 x |
| FCF Yield | -13.8% | -18.4% | -15% | -6.28% | -18.2% | 1.41% |
| Price to Book | 1.56 x | 1.55 x | 0.74 x | 0.99 x | 1.28 x | 1.82 x |
| Nbr of stocks (in thousands) | 12,400 | 12,400 | 12,400 | 12,400 | 12,400 | 12,400 |
| Reference price 2 | 4.400 | 4.400 | 1.900 | 1.750 | 2.230 | 1.710 |
| Announcement Date | 17/05/18 | 23/05/19 | 17/06/20 | 01/07/21 | 15/06/22 | 05/07/23 |
1TND in Million2TND
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net sales 1 | 38.14 | 46.72 | 42.53 | 35.43 | 63.3 | 58.16 |
| EBITDA 1 | 8.232 | 9.447 | 4.747 | -1.546 | 11.58 | 2.775 |
| EBIT 1 | 5.186 | 5.44 | 0.0455 | -6.924 | 4.873 | -3.534 |
| Operating Margin | 13.6% | 11.64% | 0.11% | -19.54% | 7.7% | -6.08% |
| Earnings before Tax (EBT) 1 | 2.431 | 1.206 | -3.672 | -12.9 | -0.0675 | -9.814 |
| Net income 1 | 2.168 | 0.9931 | -3.754 | -12.97 | -0.1949 | -9.941 |
| Net margin | 5.69% | 2.13% | -8.83% | -36.6% | -0.31% | -17.09% |
| EPS 2 | 0.1749 | 0.0801 | -0.3027 | -1.046 | -0.0157 | -0.8017 |
| Free Cash Flow 1 | -12.05 | -19.68 | -13.81 | -6.445 | -22.58 | 1.674 |
| FCF margin | -31.6% | -42.12% | -32.48% | -18.19% | -35.67% | 2.88% |
| FCF Conversion (EBITDA) | - | - | - | - | - | 60.31% |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 17/05/18 | 23/05/19 | 17/06/20 | 01/07/21 | 15/06/22 | 05/07/23 |
1TND in Million2TND
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 32.6 | 52.7 | 68.4 | 80.9 | 96.2 | 97.5 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 3.958 x | 5.574 x | 14.42 x | -52.31 x | 8.309 x | 35.12 x |
| Free Cash Flow 1 | -12.1 | -19.7 | -13.8 | -6.45 | -22.6 | 1.67 |
| ROE (net income / shareholders' equity) | 8.45% | 2.83% | -11.2% | -48.4% | -0.9% | -59.8% |
| ROA (Net income/ Total Assets) | 3.97% | 3.22% | 0.02% | -3.03% | 1.97% | -1.34% |
| Assets 1 | 54.56 | 30.81 | -17,378 | 427.3 | -9.874 | 740.8 |
| Book Value Per Share 2 | 2.820 | 2.830 | 2.550 | 1.770 | 1.740 | 0.9400 |
| Cash Flow per Share 2 | 0.3800 | 0.2500 | 0.2000 | 0.2400 | 0.2800 | 0.2100 |
| Capex 1 | 9.59 | 21.6 | 22 | 8.94 | 19.9 | 7.08 |
| Capex / Sales | 25.13% | 46.3% | 51.72% | 25.22% | 31.41% | 12.18% |
| Announcement Date | 17/05/18 | 23/05/19 | 17/06/20 | 01/07/21 | 15/06/22 | 05/07/23 |
1TND in Million2TND
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -0.79% | 4.94M | |
| -20.57% | 1.25B | |
| -14.03% | 1.05B | |
| +3.75% | 1.03B | |
| +27.87% | 769M | |
| -18.23% | 342M | |
| +25.24% | 234M | |
| +20.79% | 187M | |
| -3.57% | 90.91M | |
| +41.18% | 65.16M |
- Stock Market
- Equities
- SANIMED Stock
- Financials Sanimed Société Anonyme